Search research articles
Contact Us
Filters
Showing results (591-600 of 959) with videos related to
Page
of 96
Sort By:
Journal of Global Antimicrobial Resistance
|
November 19, 2022
Real world efficacy of dolutegravir plus lamivudine in people living with HIV with undetectable viral load after previous failures
Roberta Gagliardini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
The Lancet. Rheumatology
|
January 22, 2024
The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution
Gemma Lepri, Michael Hughes, Yannick Allanore, et al.
Journal of Toxicology and Environmental Health. Part A
|
January 27, 2024
Piperlongumine inhibits antioxidant enzymes, increases ROS levels, induces DNA damage and G2/M cell cycle arrest in breast cell lines
Adrivanio Baranoski, Simone Cristine Semprebon, Bruna Isabela Biazi, et al.
Journal of Hazardous Materials
|
November 26, 2021
Modified dry bean pod waste (Phaseolus vulgaris) as a biosorbent for fluorescein removal from aqueous media: Batch and fixed bed studies
Igor C De Sá, P M De Oliveira, E Nossol, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
June 19, 2020
[Surveillance of acute flaccid paralysis in Ivory Coast between 2007 and 2016: Significance and epidemiological profile of non-poliovirus enteroviruses]
Lepri Bernadin Nicaise Aka, Kouadio Daniel Ekra, Gnissan Henri Auguste Yao, et al.
Plos One
|
October 8, 2016
Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice
Silvia Costarelli, Alessandro Cozzi-Lepri, Giuseppe Lapadula, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 15, 2005
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients
Antonella d'arminio Monforte, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
HIV Medicine
|
June 5, 2024
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy
Vincenzo Malagnino, Alessandro Cozzi-Lepri, Valentina Svicher, et al.
The Journal of Antimicrobial Chemotherapy
|
February 13, 2023
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study
Antonella D'arminio Monforte, Alessandro Tavelli, Matteo Sala, et al.
The Journal of Antimicrobial Chemotherapy
|
September 23, 2025
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort
Alessandra Vergori, Alessandro Cozzi-Lepri, Sergio Lo Caputo, et al.
Page
of 96
Search research articles
Search
Showing results (591-600 of 959) with videos related to
Sort By:
Page
of 96
Journal of Global Antimicrobial Resistance
|
November 19, 2022
Real world efficacy of dolutegravir plus lamivudine in people living with HIV with undetectable viral load after previous failures
Roberta Gagliardini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
The Lancet. Rheumatology
|
January 22, 2024
The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution
Gemma Lepri, Michael Hughes, Yannick Allanore, et al.
Journal of Toxicology and Environmental Health. Part A
|
January 27, 2024
Piperlongumine inhibits antioxidant enzymes, increases ROS levels, induces DNA damage and G2/M cell cycle arrest in breast cell lines
Adrivanio Baranoski, Simone Cristine Semprebon, Bruna Isabela Biazi, et al.
Journal of Hazardous Materials
|
November 26, 2021
Modified dry bean pod waste (Phaseolus vulgaris) as a biosorbent for fluorescein removal from aqueous media: Batch and fixed bed studies
Igor C De Sá, P M De Oliveira, E Nossol, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
June 19, 2020
[Surveillance of acute flaccid paralysis in Ivory Coast between 2007 and 2016: Significance and epidemiological profile of non-poliovirus enteroviruses]
Lepri Bernadin Nicaise Aka, Kouadio Daniel Ekra, Gnissan Henri Auguste Yao, et al.
Plos One
|
October 8, 2016
Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice
Silvia Costarelli, Alessandro Cozzi-Lepri, Giuseppe Lapadula, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 15, 2005
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients
Antonella d'arminio Monforte, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
HIV Medicine
|
June 5, 2024
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy
Vincenzo Malagnino, Alessandro Cozzi-Lepri, Valentina Svicher, et al.
The Journal of Antimicrobial Chemotherapy
|
February 13, 2023
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study
Antonella D'arminio Monforte, Alessandro Tavelli, Matteo Sala, et al.
The Journal of Antimicrobial Chemotherapy
|
September 23, 2025
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort
Alessandra Vergori, Alessandro Cozzi-Lepri, Sergio Lo Caputo, et al.
Page
of 96